Spin-out companies
Source: https://warwick.ac.uk/services/innovations/partnerships/spinouts/ Parent: https://warwick.ac.uk/business/
Spin-out Companies
We have created over 100 spinout companies, more than any other Midlands University. As at 31st July 2025, the University held investments in 31 active spin-outs, disclosed in the 2024/25 Financial Statements. A selection of these, are detailed below. *The University no longer has an investment in Interface Polymers.
Work with our spin-outs
Could you be a mentor, CEO or board member? Get in touch to connect with our spin-outs.
UK GOVERNMENT SPINOUT REVIEW: STATEMENT OF BEST PRACTICE ADOPTION
09 September 2024
Warwick Innovations welcomed the UK Government Spinout Review and the opportunity to revise the University’s institutional policies and practice around spinout company development. The university is committed to update policy and practice (subject to UEB and FGPC approval) to better align with recommendations from the Spinout Review. Key policy changes under consideration at Warwick are to:
- reduce the university’s equity stake in future spinouts up to 30%. This stake could be lower subject to the nature of the IP and market sector; and
- to recognise academic founders in addition to Creators in being able to benefit from shares in spinout equity.
Other key changes in spinout company development and support being implemented at Warwick are to:
- define, communicate and refine steps and timelines for spinout company formation, including clarity on expectations from key stakeholders;
- embed a new process to better manage, support and report on spinout portfolio performance;
- deliver a campus-wide marcomms campaign to raise awareness of changes in our spinout policy and practice; and
- roll-out a series of internal programmes to upskill the research community in commercialisation skills and innovation leadership.
Select all Select all tags / none Unselect all tags
Select tags to filter on
AI & Data
Energy & environment
Engineering, Materials & Manufacturing
Medtech & diagnostics
Therapeutics
22 Feb 2024
Lightcast Discovery
Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function.
Tags: Medtech & diagnostics, Therapeutics
15 Nov 2023
Sonemat
At Sonemat our goal is to deliver innovative ultrasonic NDT solutions to today’s Non-Destructive Testing (NDT) issues.
Tags: Engineering, Materials & Manufacturing
15 Nov 2023
Warwick Acoustics
Warwick Acoustics creates ground-breaking electrostatic audio products designed with a single-minded mission; to deliver truly remarkable listening experiences.
Tags: Engineering, Materials & Manufacturing
15 Nov 2023
Advanced Epi
Bespoke epitaxial growth services for Group IV semiconductors - Si, Ge, SiC, SiGe, GeSn
Tags: Engineering, Materials & Manufacturing
15 Nov 2023
Cytecom
Harnessing electricity for rapid microbial detection & novel investigatory yools.
Tags: Engineering, Materials & Manufacturing
15 Nov 2023
Stoli Chem
Continuous chemical reactors from lab to production
Tags: Engineering, Materials & Manufacturing
08 Nov 2023
Verdel Instruments
3D Mass Spectrometry - total correlation mass spectrometry (TOC-MS) showing the complete picture for every analyte.
Tags: Engineering, Materials & Manufacturing
30 Oct 2023
Spectra Analytics/Patchs Health
One destination for your healthcare needs
Tags: AI & Data
30 Oct 2023
Tangent Reprofiling/Valiseek
ValiSeek is ValiRx's Joint Venture Company, formed with Tangent Reprofiling Limited to rapidly progress VAL401 through development. VAL401 is in development for Pancreatic ductal adenocarcinoma.
Tags: Therapeutics
30 Oct 2023
Seev Technologies Limited
Voting software that eliminates fraud. E2E verifiable voting is ideal for contested elections, AGM, shareholder voting, leadership elections and awards.
Tags: AI & Data
30 Oct 2023
Clinvivo
Clinvivo Ltd. specialise in data capture in clinical trials of complex interventions and health research.
Tags: AI & Data, Medtech & diagnostics
30 Oct 2023
OVO Biomanufacturing
OVO Biomanufacturing are the world leading experts in providing technical solutions to solve the effects of defective interfering particles for viral vaccine manufacturers.
Tags: Medtech & diagnostics, Engineering, Materials & Manufacturing
30 Oct 2023
NanoSyrinx Ltd
NanoSyrinx is a discovery stage synthetic biology company creating a next-generation platform technology for the targeted intracellular delivery of biological molecules.
Tags: Medtech & diagnostics
30 Oct 2023
Medherant
Improving patient care through innovation in transdermal drug delivery.
Tags: Medtech & diagnostics
30 Oct 2023
Histofy
Optimising cellular pathology with cutting-edge artificial intelligence
Tags: AI & Data, Medtech & diagnostics
30 Oct 2023
Erebagen
Erebagen is a synthetic biology company that discovers truly novel bioactive products from microbes by activating previously silent gene clusters.
Tags: Medtech & diagnostics
30 Oct 2023
Biofidelity
Biomarker testing technology developed to provide comprehensive biomarker results within days of diagnosis, giving physicians the opportunity to offer their patients the best possible treatment options.
Tags: Medtech & diagnostics
30 Oct 2023
4D Biomaterials
Pioneering the commercialisation of a new class of 3D printable resorbable biomaterials for diverse medical applications.
Tags: Medtech & diagnostics
24 Jun 2023
Interface Polymers
We are about to revolutionise the polyolefin industry.. With radical new solutions to long-standing compatibility problems, we are opening up a new world of opportunities in polymer blending, joining and finishing.
Tags: Engineering, Materials & Manufacturing
09 Aug 2022
NeuroSolutions
NeuroSolutions is a contract research organisation established in 2001 as a service provider of cutting edge electrophysiological and behavioural research in the field of neuroscience.